CSIMarket
 
Glucotrack Inc   (NASDAQ: GCTK)
 
Price: $2.3100 $0.04 1.762%
Day's High: $2.309999942779541 Week Perf: -28.48 %
Day's Low: $ 2.20 30 Day Perf: 575.44 %
Volume (M): 28,355 52 Wk High: $ 9.09
Volume (M$): $ 0 52 Wk Avg: $2.64
Open: $2.25 52 Wk Low: $0.25



 Market Capitalization (Millions $) 1
 Shares Outstanding (Millions) 0
 Employees 15
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) 8
 Cash Flow (TTM) (Millions $) -6
 Capital Exp. (TTM) (Millions $) 0

Business Description


Glucotrack Inc is a medical technology company that specializes in the development and manufacturing of non-invasive glucose monitoring devices. The company's flagship product, also called Glucotrack, is designed to help people with diabetes manage their blood sugar levels more easily and conveniently. Unlike traditional glucose monitoring devices that require blood samples, Glucotrack uses a combination of ultrasonic, electromagnetic, and thermal technologies to measure glucose levels in the saliva or outer earlobe. This non-invasive approach eliminates the need for painful finger pricking and provides accurate and real-time glucose readings. The company aims to improve the lives of individuals with diabetes by offering a non-invasive and user-friendly alternative to glucose monitoring.


   Company Address: 301 Route 17 North Rutherford 7070 NJ
   Company Phone Number: 842-7715   Stock Exchange / Ticker: NASDAQ GCTK


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
DRIO        2.49% 
DXCM        4.12% 
MDT        0.77% 
NDRA   -9.09%    
VANI   -5.7%    
MOVE   -21.16%    
• View Complete Report
   



Shares

Glucotrack Ignites Reformative Strategies: Unveils 1-for-20 Reverse Stock Split with Strategic CFO Appointment Amid Evolving Market Dynamics,

Published Thu, Jan 30 2025 1:01 PM UTC

In a decisive move set to realign its financial standing and enhance shareholder value, Glucotrack, Inc. has announced a 1-for-20 reverse stock split, which will take effect as the trading day begins on February 4, 2025. This corporate action is designed to consolidate every 20 shares of the company’s stock into a single share, reducing the number of outstanding shares and...

Management Changes

Glucotracks Strategic Reinforcement: Industry Veteran Peter C. Wulff Appointed CFO Amidst Financial Challenges

Published Wed, Jan 29 2025 2:01 PM UTC

In a significant development for Glucotrack, the company has bolstered its executive leadership with the appointment of industry veteran Peter C. Wulff as the new Chief Financial Officer. This strategic move comes at a crucial time as Glucotrack seeks to enhance its financial strategy and accelerate the commercialization of its innovative continuous blood glucose monitor, sp...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 0.07
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.38
Working Capital Ratio 0.46
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) 4.09

Per Share Current
Earnings (TTM) 33.15 $
Revenues (TTM) -
Cash Flow (TTM) -
Cash 3.37 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) 554,600
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) -
Asset Turnover Ratio (TTM) -

Profitability Ratios Current
Gross Margin (MRQ) -
Operating Margin (MRQ) -
Net Margin (MRQ) -
Net Cash Flow Margin (MRQ) -
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 151.4 %
Return On Investment (TTM) 843.28 %
Return On Equity (TTM) 1114.03 %
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.